Healthcare provider profile · identity verified

Binh Lam, MD

Internal Medicine · ELMHURST, NY · NPI 1841228095

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	904	297
Amlodipine Besylate	Amlodipine Besylate	566	188
Losartan Potassium	Losartan Potassium	450	144
Metoprolol Succinate	Metoprolol Succinate	391	125
Metformin Hcl	Metformin Hcl	291	97
Levothyroxine Sodium	Levothyroxine Sodium	275	85
Simvastatin	Simvastatin	253	82
Tamsulosin Hcl	Tamsulosin Hcl	232	73
Rosuvastatin Calcium	Rosuvastatin Calcium	191	69
Glimepiride	Glimepiride	176	59
Metformin Hcl Er	Metformin Hcl	173	63
Omeprazole	Omeprazole	164	59
Lisinopril	Lisinopril	163	49
Ozempic	Semaglutide	159	37
Hydrochlorothiazide	Hydrochlorothiazide	143	48
Eliquis	Apixaban	142	36
Gabapentin	Gabapentin	142	45
Carvedilol	Carvedilol	139	40
Famotidine	Famotidine	130	53
Finasteride	Finasteride	130	44
Irbesartan	Irbesartan	130	42
Mirtazapine	Mirtazapine	122	38
Allopurinol	Allopurinol	118	41
Albuterol Sulfate Hfa	Albuterol Sulfate	116	41
Clopidogrel	Clopidogrel Bisulfate	101	33
Fluticasone Propionate	Fluticasone Propionate	101	43
Alendronate Sodium	Alendronate Sodium	92	37
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	87	26
Diclofenac Sodium	Diclofenac Sodium	85	26
Triamcinolone Acetonide	Triamcinolone Acetonide	85	50
Tizanidine Hcl	Tizanidine Hcl	82	26
Metoprolol Tartrate	Metoprolol Tartrate	81	29
Montelukast Sodium	Montelukast Sodium	77	23
Atenolol	Atenolol	75	23
Furosemide	Furosemide	71	29
Betamethasone Dipropionate	Betamethasone Dipropionate	66	26
Zolpidem Tartrate	Zolpidem Tartrate	64	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	22
Pantoprazole Sodium	Pantoprazole Sodium	62	25
Ibuprofen	Ibuprofen	56	30
Meclizine Hcl	Meclizine Hcl	55	28
Alprazolam	Alprazolam	50	18
Jardiance	Empagliflozin	49	18
Oxybutynin Chloride Er	Oxybutynin Chloride	49	16
Farxiga	Dapagliflozin Propanediol	48	17
Single Use Swab	Alcohol Antiseptic Pads	46	13
Januvia	Sitagliptin Phosphate	44	12
Memantine Hcl	Memantine Hcl	44	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	15
Symbicort	Budesonide/Formoterol Fumarate	42	suppressed
Donepezil Hcl	Donepezil Hcl	40	15
Ketoconazole	Ketoconazole	39	21
Glipizide	Glipizide	38	11
Meloxicam	Meloxicam	38	21
Prednisone	Prednisone	38	29
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	26
Enalapril Maleate	Enalapril Maleate	37	suppressed
Ammonium Lactate	Ammonium Lactate	36	suppressed
Azelastine Hcl	Azelastine Hcl	36	18
Fenofibrate	Fenofibrate Nanocrystallized	36	12
Buspirone Hcl	Buspirone Hcl	35	13
Clonazepam	Clonazepam	35	suppressed
Eszopiclone	Eszopiclone	35	suppressed
Synthroid	Levothyroxine Sodium	35	16
Warfarin Sodium	Warfarin Sodium	34	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	33	13
Escitalopram Oxalate	Escitalopram Oxalate	33	11
Pioglitazone Hcl	Pioglitazone Hcl	33	13
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	32	suppressed
Valsartan	Valsartan	32	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	13
Ramipril	Ramipril	29	suppressed
Lovastatin	Lovastatin	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	27	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	27	suppressed
Spironolactone	Spironolactone	27	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Phenobarbital	Phenobarbital	26	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Lactulose	Lactulose	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	22	12
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Azithromycin	Azithromycin	22	22
Cilostazol	Cilostazol	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Telmisartan	Telmisartan	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	20	suppressed
Fenofibrate	Fenofibrate,micronized	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Sertraline Hcl	Sertraline Hcl	18	suppressed
Tramadol Hcl Er	Tramadol Hcl	18	suppressed
Cephalexin	Cephalexin	17	13
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	15	12
Nystatin	Nystatin	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Betamethasone Valerate	Betamethasone Valerate	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Potassium Chloride	Potassium Chloride	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Verapamil Er	Verapamil Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Anastrozole	Anastrozole	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Ciclopirox	Ciclopirox Olamine	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error